The Hidden Saboteur: Gut-Driven Systemic Inflammation
Most athletes and biohackers view injury healing as a local problem. You ice the ankle, you inject the BPC-157, and you wait. But if your C-Reactive Protein (CRP) levels are high because of intestinal permeability, your recovery will move at a snail’s pace.
Think of your gut lining as a finely woven mesh: a selective filter that lets nutrients in and keeps “the bad stuff” out. When this mesh is damaged, a process known as leaky gut (or increased intestinal permeability) occurs.
One of the most dangerous escapees is Lipopolysaccharide (LPS). This is a toxin from bacterial cell walls that, once in your bloodstream, triggers a cascade of systemic inflammation. Your body enters a state of “high alert,” and suddenly, that localized repair work on your tendon takes a backseat to a full-blown immune response.
Enter Larazotide (AT-1001): The Tight Junction Architect
Larazotide (AT-1001) is a locally acting, non-systemic octapeptide. In plain English? It stays in your gut to do its job and doesn’t wander off into the rest of your body. Its scientific classification is a zonulin receptor antagonist.
The Zonulin Connection
To understand Larazotide, you have to understand Zonulin. Zonulin is the “master key” that controls the “zippers” between your gut cells, known as Tight Junctions.
- The Problem: Triggers like gluten, stress, or certain toxins cause a massive release of zonulin. This “unlocks” the tight junctions, leaving the door wide open for inflammation-causing antigens to flood your system.
- The High-Tech Solution: Larazotide acts as the “locksmith.” It blocks the zonulin receptors (specifically the EGFR/PAR2 complex), preventing the signaling cascade that pulls the tight junctions apart. It essentially “Re-zips” your gut lining.
